OKYO Pharma (OKYO) Assets (2021 - 2025)

OKYO Pharma (OKYO) has 5 years of Assets data on file, last reported at $4.6 million in Q3 2025.

• Assets for Q3 2025 came in at $4.6 million, up 64.16% year-over-year; the trailing twelve-month figure through Sep 2025 was $4.6 million (up 64.16% YoY), and the FY2025 annual result was $3.7 million, up 138.59% from the prior year.
• Assets improved to $4.6 million in Q3 2025 per OKYO's latest filing, from $3.7 million in the prior quarter.
• Over five years, Assets peaked at $7.1 million in Q1 2021 and troughed at $1.5 million in Q1 2024.
• A 5-year average of $4.0 million and a median of $4.0 million in 2022 frame the typical range for Assets.
• The sharpest annual moves came in 2024 and 2025: Assets tumbled 70.38% in 2024, then soared 138.59% in 2025.
• A 5-year view of Assets shows it stood at $7.1 million in 2021, then sank by 39.35% to $4.3 million in 2022, then sank by 44.72% to $2.4 million in 2023, then rose by 19.0% to $2.8 million in 2024, then jumped by 64.16% to $4.6 million in 2025.
• Business Quant data shows OKYO's Assets at $4.6 million in Q3 2025, $3.7 million in Q1 2025, and $2.8 million in Q3 2024.